Fenitrothion


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:11222873IVR15 mg/kg 15 mg/kgAffects acetylcholinesterase activityNeurological endocrine-mediated perturbations
IVR15 mg/kg 15 mg/kgDecreased weights of seminal vesiclesReproductive endocrine-mediated perturbations
IVR15 mg/kg 15 mg/kgDecreased weights of bulbocavernosus muscles/LABCReproductive endocrine-mediated perturbations
IVR15 mg/kg 15 mg/kgDecreased weights of accessory sex organsReproductive endocrine-mediated perturbations
IVR15 mg/kg 15 mg/kgDecreased prostate weightsReproductive endocrine-mediated perturbations
IVR30 mg/kg 30 mg/kgAffects social behaviorNeurological endocrine-mediated perturbations
IVR30 mg/kg 30 mg/kgReduced acetylcholinesterase activityNeurological endocrine-mediated perturbations
IVTH0.0000000001 - 0.00001 M 0.00000001 - 0.000001 MDecreased Dihydroxytestosterone (DHT) levelsReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.